Article

You have full text access to this OnlineOpen article

Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity

  1. Pravin Kumar1,†,
  2. Ardeschir Vahedi-Faridi2,†,
  3. Wolfram Saenger2,
  4. Andreas Ziegler1,*,
  5. Barbara Uchanska-Ziegler1

Article first published online: 2 DEC 2008

DOI: 10.1002/pro.4

Issue

Protein Science

Protein Science

Volume 18, Issue 1, pages 37–49, January 2009

Additional Information

How to Cite

Kumar, P., Vahedi-Faridi, A., Saenger, W., Ziegler, A. and Uchanska-Ziegler, B. (2009), Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity. Protein Science, 18: 37–49. doi: 10.1002/pro.4

Author Information

  1. 1

    Institut für Immungenetik, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Freie Universität Berlin, Thielallee 73, Berlin 14195, Germany

  2. 2

    Institut für Chemie und Biochemie/Kristallographie, Freie Universität Berlin, Takustrasse 6, Berlin 14195, Germany

  1. †

    Pravin Kumar and Ardeschir Vahedi-Faridi contributed equally to this work.

*Institut für Immungenetik, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Freie Universität Berlin, Thielallee 73, 14195 Berlin, Germany

Publication History

  1. Issue published online: 16 DEC 2008
  2. Article first published online: 2 DEC 2008
  3. Manuscript Accepted: 13 OCT 2008
  4. Manuscript Revised: 6 OCT 2008
  5. Manuscript Received: 30 AUG 2008

Funded by

  • Deutsche Forschungsgemeinschaft. Grant Number: SfB 449/B6
  • Senate of Berlin (NaFöG Fellowship)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (7122K)

References

  • 1
    Madden DR ( 1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13: 587–622.
  • 2
    Rudolph MG, Stanfield RL, Wilson IA ( 2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419–466.
  • 3
    Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD ( 2000) Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537–543.
  • 4
    Fan QR, Long EO, Wiley DC ( 2001) Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2: 452–460.
  • 5
    Krogsgaard M, Davis MM ( 2005) How T cells ‘see’ antigen. Nat Immunol 6: 239–245.
  • 6
    Deng L, Mariuzza RA ( 2007) Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Trends Biochem Sci 32: 500–508.
  • 7
    Godfrey DI, Rossjohn J, McCluskey J ( 2008) The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 28: 304–314.
  • 8
    Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG ( 1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290–296.
  • 9
    Guo HC, Madden DR, Silver ML, Jardetzky TS, Gorga JC, Strominger JL, Wiley DC ( 1993) Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. Proc Natl Acad Sci USA 90: 8053–8057.
  • 10
    Rammensee HG, Falk K, Rotzschke O ( 1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11: 213–244.
  • 11
    DiBrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE ( 1993) HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol 151: 5930–5935.
  • 12
    Falk K, Rötzschke O, Takiguchi M, Grahovac B, Gnau V, Stevanovic S, Jung G, Rammensee HG ( 1994) Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40: 238–241.
  • 13
    Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, Zhu NZ, Arnott D, Sherman N, Shabanowitz J, Michel H ( 1994) Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 152: 3913–3924.
  • 14
    Hülsmeyer M, Chames P, Hillig RC, Stanfield RL, Held G, Coulie PG, Alings C, Wille G, Saenger W, Uchanska-Ziegler B, Hoogenboom HR, Ziegler A ( 2005) A major histocompatibility complex-peptide-restricted antibody and T cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with Fab-Hyb3. J Biol Chem 280: 2972–2980.
  • 15
    Armstrong KM, Insaidoo FK, Baker BM ( 2008) Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities. J Mol Recognit 21: 275–287.
    Direct Link:
  • 16
    Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC ( 1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134–141.
  • 17
    van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T ( 1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643–1647.
  • 18
    Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S ( 2001) An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61: 5544–5551.
  • 19
    Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P ( 2006) Human T cell responses against melanoma. Annu Rev Immunol 24: 175–208.
  • 20
    Renkvist N, Castelli C, Robbins PF, Parmiani G ( 2001) A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 50: 3–15.
  • 21
    Ziegler A, Coulie PG, Uchanska-Ziegler B ( 2007) Monoclonal and recombinant antibodies with T cell receptor-like reactivity. Recent Results Cancer Res 176: 229–241.
  • 22
    Chlewicki LK, Holler PD, Monti BC, Clutter MR, Kranz DM ( 2005) High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol 346: 223–239.
  • 23
    Abastado JP, Darche S, Jouin H, Delarbre C, Gachelin G, Kourilsky P ( 1989) A monoclonal antibody recognizes a subset of the H-2Dd mouse major class I antigens. Res Immunol 140: 581–594.
  • 24
    Aharoni R, Teitelbaum D, Arnon R, Puri J ( 1991) Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature 351: 147–150.
  • 25
    Murphy DB, Rath S, Pizzo E, Rudensky AY, George A, Larson JK, Janeway CA, Jr ( 1992) Monoclonal antibody detection of a major self peptide. MHC class II complex. J Immunol 148: 3483–3491.
  • 26
    Uchanska-Ziegler B, Nössner E, Schenk A, Ziegler A, Schendel DJ ( 1993) Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TÜ165). Eur J Immunol 23: 734–738.
    Direct Link:
  • 27
    Wang J, Yu DT, Fukazawa T, Kellner H, Wen J, Cheng XK, Roth G, Williams KM, Raybourne RB ( 1994) A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J Immunol 152: 1197–1205.
  • 28
    Eastman S, Deftos M, DeRoos PC, Hsu DH, Teyton L, Braunstein NS, Hackett CJ, Rudensky A ( 1996) A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody. Eur J Immunol 26: 385–393.
    Direct Link:
  • 29
    Dadaglio G, Nelson CA, Deck MB, Petzold SJ, Unanue ER ( 1997) Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6: 727–738.
  • 30
    Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN ( 1997) Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715–726.
  • 31
    Rehm A, Rohr A, Seitz C, Wonigeit K, Ziegler A, Uchanska-Ziegler B ( 2000) Structurally diverse forms of HLA-B27 molecules are displayed in vivo in a cell type-dependent manner. Hum Immunol 61: 408–418.
  • 32
    Chames P, Hufton SE, Coulie PG, Uchanska-Ziegler B, Hoogenboom HR ( 2000) Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library. Proc Natl Acad Sci USA 97: 7969–7974.
  • 33
    Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA ( 1995) Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA 92: 2479–2483.
  • 34
    Zhao R, Loftus DJ, Appella E, Collins EJ ( 1999) Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J Exp Med 189: 359–370.
  • 35
    Madden DR, Garboczi DN, Wiley DC ( 1993) The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693–708.
  • 36
    Kjer-Nielsen L, Clements CS, Brooks AG, Purcell AW, Fontes MR, McCluskey J, Rossjohn J ( 2002) The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J Immunol 169: 5153–5160.
  • 37
    Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, Silins SL, van Zuylen WJ, Purcell AW, Kjer-Nielsen L, McCluskey J, Burrows SR, Rossjohn J ( 2005) High resolution structures of highly bulged viral epitopes bound to the major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem 280: 23900–23909.
  • 38
    Reiser JB, Gregoire C, Darnault C, Mosser T, Guimezanes A, Schmitt-Verhulst AM, Fontecilla-Camps JC, Mazza G, Malissen B, Housset D ( 2002) A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16: 345–354.
  • 39
    Fremont DH, Matsumura M, Stura EA, Peterson PA, Wilson IA ( 1992) Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257: 919–927.
  • 40
    Reiser JB, Darnault C, Gregoire C, Mosser T, Mazza G, Kearney A, van der Merwe PA, Fontecilla-Camps JC, Housset D, Malissen B ( 2003) CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat Immunol 4: 241–247.
  • 41
    Luz JG, Huang M, Garcia KC, Rudolph MG, Apostolopoulos V, Teyton L, Wilson IA ( 2002) Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) interactions. J Exp Med 195: 1175–1186.
  • 42
    Fan QR, Wiley DC ( 1999) Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J Exp Med 190: 113–123.
  • 43
    Mareeva T, Martinez-Hackert E, Sykulev Y ( 2008) How a TCR-like antibody recognizes MHC-bound peptide. J Biol Chem 283: 29053–29059.
  • 44
    Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ ( 2003) A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. Immunity 19: 595–606.
  • 45
    Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, Burrows SR, McCluskey J, Rossjohn J ( 2003) A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18: 53–64.
  • 46
    Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J ( 2005) T cell receptor recognition of a ‘super-bulged’ major histocompatibility complex class I-bound peptide. Nat Immunol 6: 1114–1122.
  • 47
    Reiser JB, Darnault C, Guimezanes A, Gregoire C, Mosser T, Schmitt-Verhulst AM, Fontecilla-Camps JC, Malissen B, Housset D, Mazza G ( 2000) Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat Immunol 1: 291–297.
  • 48
    Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, Wilson IA ( 1998) Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279: 1166–1172.
  • 49
    Tynan FE, Reid HH, Kjer-Nielsen L, Miles JJ, Wilce MC, Kostenko L, Borg NA, Williamson NA, Beddoe T, Purcell AW, Burrows SR, McCluskey J, Rossjohn J ( 2007) A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol 8: 268–276.
  • 50
    Narzi D, Winkler K, Saidowsky J, Misselwitz R, Ziegler A, Bockmann RA, Alexiev U ( 2008) Molecular determinants of major histocompatibility complex class I complex stability: shaping antigenic features through short and long range electrostatic interactions. J Biol Chem 283: 23093–23103.
  • 51
    Marrack P, Rubtsova K, Scott-Browne J, Kappler JW ( 2008) T cell receptor specificity for major histocompatibility complex proteins. Curr Opin Immunol 20: 203–207.
  • 52
    Huseby ES, White J, Crawford F, Vass T, Becker D, Pinilla C, Marrack P, Kappler JW ( 2005) How the T cell repertoire becomes peptide and MHC specific. Cell 122: 247–260.
  • 53
    Huseby ES, Kappler JW, Marrack P ( 2008) Thymic selection stifles TCR reactivity with the main chain structure of MHC and forces interactions with the peptide side chains. Mol Immunol 45: 599–606.
  • 54
    Adams EJ, Chien YH, Garcia KC ( 2005) Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science 308: 227–231.
  • 55
    Garboczi DN, Hung DT, Wiley DC ( 1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89: 3429–3433.
  • 56
    Leslie A. MOSFLM users guide. Cambridge, UK: MRC Laboratory of Molecular Biology; 1995.
  • 57
    Kabsch W ( 1988) Evaluation of single-crystal X-ray diffraction data from a position-sensitive detector. J Appl Crystallogr 21: 916–924.
    Direct Link:
  • 58
    Vagin A, Teplyakov A ( 1997) MOLREP: an automated program for molecular replacement. J Appl Crystallogr 30: 1022–1025.
    Direct Link:
  • 59
    McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ ( 2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61: 458–464.
    Direct Link:
  • 60
    Murshudov GN, Vagin AA, Dodson EJ ( 1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240–255.
    Direct Link:
  • 61
    Emsley P, Cowtan K ( 2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
    Direct Link:
  • 62
    Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL ( 1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905–921.
    Direct Link:
  • 63
    Lee B, Richards FM ( 1971) The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55: 379–400.
  • 64
    Kabsch W, Kabsch H, Eisenberg D ( 1976) Packing in a new crystalline form of glutamine synthetase from Escherichia coli. J Mol Biol 100: 283–291.
  • 65
    DeLano W. The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific; 2002.
  • 66
    Kumar P, Ziegler A, Ziegler J, Uchanska-Ziegler B, Ziegler A ( 2008) Grasping molecular structures through publication-integrated 3D models. Trends Biochem Sci 33: 408–412.
  • 67
    Kabsch W ( 1976) A solution for the best rotation to relate two sets of vectors. Acta Crystallogr Sect A 32: 2.
    Direct Link:
View Full Article (HTML) Get PDF (7122K)